Ryan Feaver
Company: HemoShear Therapeutics, Inc.
Job title: Program Director
Seminars:
Novel Target Identification & Validation Using Complex in vitro Models & Computational Biology in NASH. 2:00 pm
• Capturing critical pathophysiologic drivers of NASH to recapitulate human disease in vitro • Utilizing diverse computational biology approaches to identify novel targets • Validating and systematically rank targets for pipeline decision-making and prioritization Ryan Feaver, Program Director, HemoShear TherapeuticsRead more
day: Day 1 Stream 1 PM